Usefulness of an S-1 dosage formula for predicting adverse events in adjuvant chemotherapy for curatively resected pancreatic cancer: an exploratory analysis of the randomized clinical trial (JASPAC-01).
Ishigaki K, Nakai Y, Kashiwabara K, Fujishiro M, Gotohda N, Toyama H, Maeda A, Shimizu Y, Miyamoto A, Takahashi A, Morinaga S, Yanagibashi H, Goto T, Sakuma Y, Tomikawa M, Ojima H, Okamura Y, Fukutomi A, Boku N, Uesaka K.
Ishigaki K, et al. Among authors: goto t.
J Gastroenterol. 2026 Apr 17. doi: 10.1007/s00535-026-02413-5. Online ahead of print.
J Gastroenterol. 2026.
PMID: 41991754